Prawo i regulacje · 26/01/2015

Apertus Pharmaceuticals Receives DEA Registration for Controlled Substance Manufacturing

Apertus Pharmaceuticals has been granted registration by the DEA as a manufacturer of a controlled substance, following its application. The company is now authorized to produce this substance, which falls under a specific basic class of controlled substances.